Recent Submissions

• Prenatal and postnatal neuroimmune interactions in neurodevelopmental disorders
• Cell-autonomous reduction of CYFIP2 is insufficient to induce Alzheimer's disease-like pathologies in the hippocampal CA1 pyramidal neurons of aged mice
• A single-component, light-assisted uncaging switch for endoproteolytic release
• Shank3a/b isoforms regulate the susceptibility to seizures and thalamocortical development in the early postnatal period of mice
• Exploring the Magnetic Properties of Individual Barcode Nanowires using Wide-Field Diamond Microscopy
• Circulating small extracellular vesicles promote proliferation and migration of vascular smooth muscle cells via AXL and MerTK activation
• The emerging roles of Shank3 in cardiac function and dysfunction
• A rationally designed optochemogenetic switch for activating canonical Wnt signaling
• miRNA-Induced Downregulation of IPMK in Macrophages Mediates Lipopolysaccharide-Triggered TLR4 Signaling
• Neuronal mitochondrial morphology is significantly affected by both fixative and oxygen level during perfusion
• CYFIP2 p.Arg87Cys Causes Neurological Defects and Degradation of CYFIP2
• Repeated ketamine anesthesia during neurodevelopment upregulates hippocampal activity and enhances drug reward in male mice
• Protein interactome and cell-type expression analyses reveal that cytoplasmic FMR1-interacting protein 1 (CYFIP1), but not CYFIP2, associates with astrocytic focal adhesion
• Isolation and analyses of lamina propria lymphocytes from mouse intestines
• Human gut bacteria produce T(H)17-modulating bile acid metabolites
• The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia
• Maternal gut bacteria drive intestinal inflammation in offspring with neurodevelopmental disorders by altering the chromatin landscape of CD4(+) T cells
• SP-1154, a novel synthetic TGF-beta inhibitor, alleviates obesity and hepatic steatosis in high-fat diet-induced mice
• KS-356, a novel inhibitor of TGF-beta superfamily signaling, improves obesity and obesity-related hepatic steatosis by inhibition of TGF-beta/Smad3 signaling pathway in high-fat diet-induced mice
• F-18 FDG PET/CT CAN BE USED AS AN IMAGING BIOMARKER FOR REFLECTING SYNTHETIC VASCULAR SMOOTH MUSCLE CELL ACTIVITY IN THE ANIMAL MODEL OF VASCULAR REMODELING DISORDER